Likely helped
- No clear beneficiaries surfaced yet.
H.R. 586 (119th)Bill Overview
Vietnam Veterans Liver Fluke Cancer Study Act
Armed Forces and National Security|Armed Forces and National SecurityAsia
Sponsor
Cosponsors
Support
Bipartisan
Introduced
Jan 21, 2025
Discussions
Bill Text
Committee
Current stageCommittee
Received in the Senate and Read twice and referred to the Committee on Veterans' Affairs.
Introduced
Committee
Floor
President
Law
01 · The brief
<p><strong>Vietnam Veterans Liver Fluke Cancer Study Act</strong></p><p>This bill requires the Department of Veterans Affairs (VA) to conduct an epidemiological study and report on the prevalence of cholangiocarcinoma (bile duct cancer) in veterans who served in the Vietnam theater of operations during the Vietnam era.
The study must identify the rate of incidence of cholangiocarcinoma in such veterans and in U.S. residents.</p><p>The bill also requires the VA to track and report on the prevalence of cholangiocarcinoma using the Veterans Affairs Central Cancer Registry.
Passage79/100
This bill has already passed one chamber, which is a stronger signal than introduction alone but still leaves another major hurdle ahead.
CredibilityPartial
How solid the drafting looks.
Contention62/100
The main political fault lines are not fully surfaced yet, so coalition durability is still unclear.
02 · What it does
Who stands to gain, and who may push back.
Who this appears to help vs burden0% / 100%
Likely helpedLikely burdened
Likely burdened
- No clear downsides surfaced yet.
03 · Why people split
Why the argument around this bill splits.
The main political fault lines are not fully surfaced yet, so coalition durability is still unclear.
Progressive—
The main political fault lines are not fully surfaced yet, so coalition durability is still unclear.
Centrist—
The main political fault lines are not fully surfaced yet, so coalition durability is still unclear.
Conservative—
The main political fault lines are not fully surfaced yet, so coalition durability is still unclear.
04 · Can it pass?
The path through Congress.
Introduced
Reached or meaningfully advanced
Committee
Reached or meaningfully advanced
Floor
Still ahead
President
Still ahead
Law
Still ahead
Passage likelihood79/100
This bill has already passed one chamber, which is a stronger signal than introduction alone but still leaves another major hurdle ahead.
Why this could stall
- The next hurdle is reproducing that support in the other chamber.
05 · Recent votes
Recent votes on the bill.
HOUSE · Apr 7, 2025
411 yes · 0 noPassed
On Motion to Suspend the Rules and Pass, as Amended
Yes 100% No 0%
Aaron Bean (FL)RR · Yes
Abraham J. Hamadeh (AZ)RR · Yes
Adam Gray (CA)DD · Yes
Adam Smith (WA)DD · Yes
Addison P. McDowell (NC)RR · Yes
Adrian Smith (NE)RR · Yes
Showing a quick cross-section of legislators, with followed members first when available.
06 · Go deeper
Go deeper than the headline read.
Included on this page
The main political fault lines are not fully surfaced yet, so coalition durability is still unclear.
This bill has already passed one chamber, which is a stronger signal than introduction alone but still leaves another major hurdle ahead.
Unlocked analysis
Pro readers get the full perspective split, passage barriers, legislative design review, stakeholder impact map, and lens-based policy tradeoff analysis for Vietnam Veterans Liver Fluke Cancer Study Act.
Go beyond the headline summary with full stakeholder mapping, legislative design analysis, passage barriers, and lens-by-lens tradeoff breakdowns.
Perspective breakdownsPassage barriersLegislative design reviewStakeholder impact map
Open full analysis